GLUE — Monte Rosa Therapeutics Share News
0.000.00%
Last trade - 00:00- $947.83m
- $326.73m
- $123.67m
U.S. STOCKS ON THE MOVE-Broadcom, home lenders, First Solar
Monte Rosa Therapeutics down after increased $300 mln equity raise
Brief: Monte Rosa Therapeutics Announces Pricing Of $300 Million Underwritten Public Offering At $24.00 Per Share
U.S. STOCKS ON THE MOVE-DoorDash, Duolingo, Gap
U.S. STOCKS ON THE MOVE-Bloom Energy, Tyson Foods, Voyager Technologies
U.S. STOCKS ON THE MOVE-Sigma Lithium, Darden Restaurants, Nike
U.S. STOCKS ON THE MOVE-Constellation Brands, General Motors, Ford
Monte Rosa Therapeutics dips after $200 mln equity offering launched
U.S. RESEARCH ROUNDUP- Alcoa, BlackRock, Evercore
Brief: Monte Rosa Therapeutics Inc - Terminates Sales Agreement Prospectus - SEC Filing
Brief: Monte Rosa Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Lowe's
U.S. STOCKS ON THE MOVE-Netflix, Alumis, Micron Technology
U.S. STOCKS ON THE MOVE-Hershey, Praxis Precision, Cal-Maine Foods
Monte Rosa rises as heart drug shows promise in early-stage trial
Brief: Monte Rosa Therapeutics Announces Compelling Clinical Activity of MRT-2359 in Combination with Enzalutamide
Monte Rosa Q3 net loss widens, but revenue increases on Novartis payment
Brief: Monte Rosa Therapeutics Q3 Operating Income USD -32.975 Million
U.S. STOCKS ON THE MOVE- Western Alliance Bancorp, CoreWeave, Alphabet